CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record

(MedPage Today) -- LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in treatment-refractory patients, according to updated results from a prospective study.
Overall, a fourth...